Mediating mechanisms for the impact of bupropion in smoking cessation treatment
- 7 May 2002
- journal article
- clinical trial
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 67 (2) , 219-223
- https://doi.org/10.1016/s0376-8716(02)00067-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- THE PHARMACOLOGY UNDERLYING PHARMACOTHERAPY FOR TOBACCO DEPENDENCE: A FOCUS ON BUPROPIONInternational Journal Of Clinical Practice, 2001
- Smoking withdrawal dynamics in unaided quitters.Journal of Abnormal Psychology, 2000
- The effect of bupropion on nicotine craving and withdrawalPsychopharmacology, 2000
- A Controlled Trial of Sustained-Release Bupropion, a Nicotine Patch, or Both for Smoking CessationNew England Journal of Medicine, 1999
- Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor BindingCellular and Molecular Neurobiology, 1999
- A Comparison of Sustained-Release Bupropion and Placebo for Smoking CessationNew England Journal of Medicine, 1997
- Listening to Nicotine: Negative Affect and the Smoking Withdrawal ConundrumPsychological Science, 1997
- Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic MechanismNeuropsychopharmacology, 1994
- Development and validation of brief measures of positive and negative affect: The PANAS scales.Journal of Personality and Social Psychology, 1988
- Effect of nicotine on the tobacco withdrawal syndromePsychopharmacology, 1984